4 mnl
This is a PSA that some of the best on the internet end in just a few hours! And that includes some pretty fab and pretty The internet's favorite and most comfortable shoes/clogs/sandals are hardly ever on sale, but as a professional shopper (no, like, actually tho), I searched high and low to find some of the best deals out there ahead of the holidays. And lucky for us, some retailers like and have special deals on select styles—I'm talking off celeb-loved Arizona Sandals! That's right, you can snag the supportive and chic slides for less than $100 right freaking now. Check out some of the best Birkenstock Cyber Monday sales, below, because they for sure won't last much longer. And while a bunch of OG styles (like the ) sadly aren't on sale, we found some pretty close dupes on for just a fraction of the price... I mean like, literally a quarter of the price. These shoes are some of the most popular and celeb-loved styles out there, so they'd also make a great holiday gift that anyone on your list is sure to love. Brand name or not! Still need some more gifting inspo? No worries. rounded up all of the best Cyber Monday sales still going on right now. Just click the button below for all of your shopping needs. Thank us later! Jasmine Hyman is the assistant shopping editor at where she covers all the best things you can add to your cart. She loves writing about everything from fashion to politics, and you can definitely find her listening to Harry Styles' entire discography on loop while doing so. She’s also probably in bed either reading or endlessly scrolling through TikTok (most likely the latter). Feel free to follow her on to be inundated with pictures of her meals.O n Tuesday a letter will land on the desk of every cabinet minister from Darren Jones, the chief secretary to the Treasury, announcing the start of the public spending review, which will decide precisely how the government spends taxpayers’ money for the next two years. It will demand three things: first, that ministers spend money on things the public actually cares about to demonstrate they are on the side of voters. Second, that they tackle waste. Every department will be told they need to find 5 per cent savings from waste and inefficiencies. Third, that they reform public services to make them more productive and get better value for money for the taxpayer. “We cannot keep paying more for poor performance,” Jones writes. This is the next step in Sir Keir Starmer’s plan to focus on the priorities of his government after he unveiled his six “milestones” last week, giving concrete targets that he aims to hit before the next election. But the exercise is about more than just improving the way government functions — it is ground zero in a battle to convince already sceptical voters that Labour is any more capable of improving their lives than the Tories were.
ANDOVER, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Mercury Systems, Inc. (NASDAQ: MRCY, www.mrcy.com ), a technology company that delivers mission-critical processing power to the edge, today announced it was awarded a two-year, $17 million development contract from a U.S. defense prime contractor for a program that leverages its Common Processing Architecture. For this follow-on program, Mercury will replace and upgrade the existing processing capabilities provided by another firm with the enhanced performance and security that its Common Processing Architecture delivers. With additional protection features including Mercury’s BuiltSECURETM technology , the system will be eligible for export to allied nations to support forward-deployed operations. The award follows a separate $49 million production agreement received in the first quarter that reflects the company’s progress in returning to full-rate production in its Common Processing Architecture product area. “These awards and others demonstrate the strong demand for secure, high-performance processing solutions at the edge, as well as our customers’ confidence in our ability to deliver these capabilities at the necessary speed and scale,” said Tom Smelker, Mercury’s Senior Vice President of Processing Technologies. Mercury Systems – Innovation that matters® Mercury Systems is a technology company that delivers mission-critical processing power to the edge, making advanced technologies profoundly more accessible for today’s most challenging aerospace and defense missions. The Mercury Processing Platform allows customers to tap into innovative capabilities from silicon to system scale, turning data into decisions on timelines that matter. Mercury’s products and solutions are deployed in more than 300 programs and across 35 countries, enabling a broad range of applications in mission computing, sensor processing, command and control, and communications. Mercury is headquartered in Andover, Massachusetts, and has 23 locations worldwide. To learn more, visit mrcy.com. (Nasdaq: MRCY) Forward-Looking Safe Harbor Statement This press release contains certain forward-looking statements, as that term is defined in the Private Securities Litigation Reform Act of 1995, including those relating to the Company's focus on enhanced execution of the Company's strategic plan. You can identify these statements by the words “may,” “will,” “could,” “should,” “would,” “plans,” “expects,” “anticipates,” “continue,” “estimate,” “project,” “intend,” “likely,” “forecast,” “probable,” “potential,” and similar expressions. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. Such risks and uncertainties include, but are not limited to, continued funding of defense programs, the timing and amounts of such funding, general economic and business conditions, including unforeseen weakness in the Company’s markets, effects of any U.S. federal government shutdown or extended continuing resolution, effects of geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in or cost increases related to completing development, engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, changes in, or in the U.S. government’s interpretation of, federal export control or procurement rules and regulations, changes in, or in the interpretation or enforcement of, environmental rules and regulations, market acceptance of the Company's products, shortages in or delays in receiving components, supply chain delays or volatility for critical components, production delays or unanticipated expenses including due to quality issues or manufacturing execution issues, capacity underutilization, increases in scrap or inventory write-offs, failure to achieve or maintain manufacturing quality certifications, such as AS9100, the impact of supply chain disruption, inflation and labor shortages, among other things, on program execution and the resulting effect on customer satisfaction, inability to fully realize the expected benefits from acquisitions, restructurings, and operational efficiency initiatives or delays in realizing such benefits, challenges in integrating acquired businesses and achieving anticipated synergies, effects of shareholder activism, increases in interest rates, changes to industrial security and cyber-security regulations and requirements and impacts from any cyber or insider threat events, changes in tax rates or tax regulations, changes to interest rate swaps or other cash flow hedging arrangements, changes to generally accepted accounting principles, difficulties in retaining key employees and customers, litigation, including the dispute arising with the former CEO over his resignation, unanticipated costs under fixed-price service and system integration engagements, and various other factors beyond our control. These risks and uncertainties also include such additional risk factors as are discussed in the Company's filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended June 28, 2024 and subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. The Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made. INVESTOR CONTACT David Williams Mercury Investor Relations David.Williams@mrcy.com MEDIA CONTACT Turner Brinton Senior Director, Corporate Communications Turner.Brinton@mrcy.comAmazon invests another $4bn in AI start-up Anthropic
REDWOOD CITY, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. BMEA ("Biomea" or the "Company"), a clinical stage biopharmaceutical company focused on the discovery and development of oral covalent small molecules to treat and improve the lives of patients with diabetes, obesity, and genetically defined cancers, today announced that on December 2, 2024, the compensation committee of Biomea's board of directors granted one new employee non-qualified stock options to purchase an aggregate of 30,000 shares of the Company's common stock. The shares underlying the employee's stock options will vest 1/16 on a quarterly basis over four years, subject to the employee's continued employment with the Company on such vesting dates. The above-described award was made under Biomea's 2023 Inducement Equity Plan (the "Plan"). The above-described award was granted as an inducement material to the employee entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and was granted pursuant to the terms of the Plan. The Plan was adopted by Biomea's board of directors on November 17, 2023. About Biomea Fusion Biomea Fusion is a clinical-stage biopharmaceutical company focused on the discovery and development of oral covalent small molecules to improve the lives of patients with diabetes, obesity, and genetically defined cancers. A covalent small molecule is a synthetic compound that forms a permanent bond to its target protein and offers a number of potential advantages over conventional non-covalent drugs, including greater target selectivity, lower drug exposure, and the ability to drive a deeper, more durable response. We are utilizing our proprietary FUSIONTM System to discover, design and develop a pipeline of next-generation covalent-binding small-molecule medicines designed to maximize clinical benefit for patients. We aim to have an outsized impact on the treatment of disease for the patients we serve. We aim to cure. Visit us at biomeafusion.com and follow us on LinkedIn , X and Facebook . Contact: Investor & Media Relations Ramses Erdtmann re@biomeafusion.com © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Losses for Big Tech pull U.S. stock indexes lower(The Center Square) – The question before the U.S. Supreme Court on Wednesday was whether a Tennessee law banning gender dysphoria treatment for minors is unconstitutional. Twenty-three other states have similar bans, but the Tennessee case is the first one to have made it to the nation's highest court. Behind the legal questions debated are medical questions that are in dispute. A transgender girl identified as "L Williams" is at the center of the case brought by the American Civil Liberties Union and later supported by the Biden administration. In an article posted on the ACLU's website, L said she was emotionally distressed as she began puberty. “You're at a point where not only are you going through puberty, but you're also going through nightmare puberty,” L said. “I mean, obviously, nobody's 100% comfortable with [the changes,] but you're immensely uncomfortable with them.” L's parents sought puberty and hormone blockers in another state when Tennessee lawmakers passed its ban in 2023. They were on the steps of the U.S. Supreme Court when the case was argued. Also on the steps was Dr. Jared Ross, a member of Do No Harm, a group of medical professionals who say their mission is to keep identity politics out of medical education, research, and clinical practice. Ross has a story, too, about a blue-haired girl who came into an emergency room one night. She described herself as "gender-confused," Ross said in an interview with The Center Square. "She was cutting herself with a razor blade because voices were telling her to," Ross said. "Can you imagine if I had affirmed these voices, affirming what she was hearing? That would have been malpractice, that would have been criminal. I didn't affirm those voices. I also didn't affirm her gender confusion." Do No Harm filed an amicus brief challenging the medical evidence presented by the ACLU and the Biden administration. It points to a study called the "Cass Review," a multi-year project from the United Kingdom that said studies of the use of puberty blockers and cross-sex hormones were uncontrolled observational studies subject to bias." The ACLU says it also has medical evidence on its side. The American Medical Association and the American College of Pediatrics are among the groups that support gender dysphoria treatment for minors. At least one medical organization is taking a second look at the treatments. The American Society of Plastic Surgeons said in April that it is reviewing the practice. "ASPS currently understands that there is considerable uncertainty as to the long-term efficacy for the use of chest and genital surgical interventions for the treatment of adolescents with gender dysphoria, and the existing evidence base is viewed as low quality/low certainty. This patient population requires specific considerations," the organization said in a statement. Doctors who don't support treatments for gender dysphoria for minors are accused of discrimination and not caring about the patients. But that's not the case, Ross said. "The other side often plays this as we're neglecting these kids or we're minimizing their suffering that they're going through," Ross said. "I don't doubt that they're suffering. They're suffering tremendously. They need love and compassion and good evidence-based mental health care." Until the Supreme Court rules in 2025, the Tennessee law and others like it will stay on the books.
Quebec Premier Wants to Put a Stop to Prayer in Parks and Public PlacesNone
Philadelphia (9-2) at Baltimore (8-4) Sunday, 4:25 p.m. EST, CBS Javascript is required for you to be able to read premium content. Please enable it in your browser settings. Get any of our free email newsletters — news headlines, obituaries, sports, and more.Vikings place LB Ivan Pace on injured reserve and sign LB Jamin Davis off Packers practice squad
AGF Fagbemi to ICC: Stop unfair probe of Nigerian militaryFACT FOCUS: Posts misrepresent Biden administration spending on EV charging stations
